Value-based pricing 'will not improve' cancer drug access
Government proposals to introduce a value-based pricing system for new drugs will not significantly improve patient access to treatments, experts have warned.
Continue reading this article – simply subscribe below
Subscribe now for instant access to hsj.co.uk and our mobile site. Choose the package that suits you and get the weekly magazine, iPad app or both.
If you are a Health Service Journal subscriber please sign in with your email address and click submit: